ROCURONIUM BROMIDE
| Brand name | ROCURONIUM BROMIDE |
|---|---|
| Active ingredient | ROCURONIUM BROMIDE |
| Strength | 50MG/5ML (10MG/ML) |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Modality | Small molecule |
| FDA approval | July 2024 |
| Marketing status | RX |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.